Combo Drug Boosts Survival in Some Women With Early Breast Cancer
FRIDAY, June 28, 20204 (HealthDay news) — An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free following treatment, a new trial shows. The combo drug, Kadcyla, is already approved to treat patients with advanced HER2-positive breast cancer, researchers said. The new results show that stage 1 breastContinue Reading










